| 1 |
33159934 | Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats. | 2021 Feb 5 |
1 |
| 2 |
33214096 | Exenatide inhibits necrosis by enhancing angiogenesis and ameliorating ischemia/reperfusion injury in a random skin flap rat model. | 2021 Jan |
1 |
| 3 |
34111331 | Spinal microglial β-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain. | 2021 Oct |
2 |
| 4 |
34234493 | An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is). | 2021 |
1 |
| 5 |
34830228 | L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease. | 2021 Nov 16 |
1 |
| 6 |
31581176 | Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats. | 2020 Feb |
1 |
| 7 |
32363414 | Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment. | 2020 Jul |
1 |
| 8 |
32563174 | The supramammillary nucleus controls anxiety-like behavior; key role of GLP-1R. | 2020 Sep |
2 |
| 9 |
32580304 | The Effects of Mutual Interaction of Orexin-A and Glucagon-Like Peptide-1 on Reflex Swallowing Induced by SLN Afferents in Rats. | 2020 Jun 22 |
1 |
| 10 |
30303298 | Effects of exendin-4 on colonic motility in rats and its underlying mechanism. | 2019 Feb |
1 |
| 11 |
30768981 | The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats. | 2019 May 5 |
1 |
| 12 |
31256933 | Exendin-4 enhances proliferation of senescent osteoblasts through activation of the IGF-1/IGF-1R signaling pathway. | 2019 Aug 13 |
2 |
| 13 |
29256971 | Cardioprotective Mechanisms of Exenatide in Isoprenaline-induced Myocardial Infarction: Novel Effects on Myocardial α-Estrogen Receptor Expression and IGF-1/IGF-2 System. | 2018 Mar |
3 |
| 14 |
29286061 | Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway. | 2018 Mar |
1 |
| 15 |
29596830 | Liposome-encapsulated clodronate specifically depletes spinal microglia and reduces initial neuropathic pain. | 2018 May 15 |
1 |
| 16 |
27518464 | Exenatide Induces Impairment of Autophagy Flux to Damage Rat Pancreas. | 2017 Jan |
2 |
| 17 |
28202578 | p38β Mitogen-Activated Protein Kinase Signaling Mediates Exenatide-Stimulated Microglial β-Endorphin Expression. | 2017 May |
1 |
| 18 |
28579479 | Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster. | 2017 Sep 1 |
1 |
| 19 |
28605180 | A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist. | 2017 Aug 18 |
4 |
| 20 |
28918840 | Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson's Disease. | 2017 Sep |
1 |
| 21 |
29084866 | Autocrine Interleukin-10 Mediates Glucagon-Like Peptide-1 Receptor-Induced Spinal Microglial β-Endorphin Expression. | 2017 Nov 29 |
1 |
| 22 |
27473212 | The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism. | 2016 Jul 30 |
1 |
| 23 |
25793496 | Proteomic analysis of INS-1 rat insulinoma cells: ER stress effects and the protective role of exenatide, a GLP-1 receptor agonist. | 2015 |
2 |
| 24 |
26546042 | Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway. | 2015 Dec |
2 |
| 25 |
24693878 | Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production. | 2014 Apr 2 |
1 |
| 26 |
24719110 | Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity. | 2014 Apr 9 |
3 |
| 27 |
25190495 | Exenatide enhances INS-1 rat pancreatic β‑cell mass by increasing the protein levels of adiponectin and reducing the levels of C-reactive protein. | 2014 Nov |
1 |
| 28 |
23354098 | Pulmonary GLP-1 receptor increases at birth and exogenous GLP-1 receptor agonists augmented surfactant-protein levels in litters from normal and nitrofen-treated pregnant rats. | 2013 Mar |
1 |
| 29 |
23692186 | Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic. | 2013 Aug |
1 |
| 30 |
23891652 | Alteration of sweet taste in high-fat diet induced obese rats after 4 weeks treatment with exenatide. | 2013 Sep |
1 |
| 31 |
22222610 | Exenatide and feeding: possible peripheral neuronal pathways. | 2012 Feb |
1 |
| 32 |
22226053 | Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight. | 2012 Jun |
1 |
| 33 |
22819704 | Effect of exendin (exenatide)--GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model. | 2012 Sep 15 |
1 |
| 34 |
21693680 | Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. | 2011 Aug |
4 |
| 35 |
19917278 | Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline. | 2010 Feb 25 |
1 |
| 36 |
20382777 | The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats. | 2010 Apr |
1 |
| 37 |
20428467 | Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac. | 2010 Mar-Apr |
1 |
| 38 |
20452329 | Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. | 2010 Jul 16 |
2 |
| 39 |
20503261 | Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein. | 2010 May |
1 |
| 40 |
20616412 | Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide. | 2010 Jul-Sep |
1 |
| 41 |
19595708 | Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo. | 2009 Oct 9 |
1 |